Franklin Wireless Stock Highlights Grant for Neuropsychiatry Research at Rosalind Franklin University

Research Breakthrough in Neuropsychiatry: Franklin University Scientist Secures Major Grant

In a significant advancement for neuropsychiatry, Joanna Dabrowska, PhD, PharmD, a neuroscientist at Rosalind Franklin University (RFU), receives a remarkable grant of $1,733,330 from the National Institute of Mental Health (NIMH). This funding supports a five-year research initiative in collaboration with the Icahn School of Medicine at Mount Sinai (ISMMS) in New York City, focusing on the neural mechanisms of social recognition memory. This area of study is particularly crucial for understanding and treating disorders such as schizophrenia and autism spectrum disorder (ASD), which impact millions of individuals in the United States.

Dr. Dabrowska, who serves as an associate professor within RFU's Center for Neurobiology of Stress Resilience and Psychiatric Disorders, examines the effects of oxytocin on the supramammillary nucleus of the hypothalamus. This brain region plays a pivotal role in processing social cues and memories. The research highlights how deficits in social recognition linked to schizophrenia—a disorder affecting approximately 2.5 million U.S. adults—and ASD, which impacts about 1 in 36 children, can severely hinder quality of life and independence. By exploring oxytocin's influence on these neural mechanisms, Dr. Dabrowska aims to identify potential therapeutic targets that could pave the way for new treatments.

The recognition of Dr. Dabrowska as an Illinois Researcher to Know by the Illinois Science and Technology Coalition underscores the significance of her work. Joseph DiMario, PhD, RFU's Executive Vice President for Research, emphasizes the importance of this collaboration with Mount Sinai, expressing optimism that their findings may lead to innovative therapeutic strategies for addressing the social deficits associated with psychiatric disorders. The study, titled "The Role of Oxytocin in Modulating Activity of the Supramammillary Nucleus (SuM) And Social Recognition Memory," reflects RFU's commitment to advancing medical science and addressing the pressing challenges posed by these mental health conditions.

In addition to Dr. Dabrowska's research, the collaboration between RFU and ISMMS signals a growing trend in the healthcare sector toward interdisciplinary partnerships aimed at tackling complex psychiatric issues. Such initiatives not only enhance the depth of scientific inquiry but also foster the development of holistic treatment approaches that can better serve affected individuals. The exploration of oxytocin's role in neuropsychiatry stands as a testament to the innovative research being conducted in this vital field.

As mental health continues to gain prominence in public discourse, the outcomes of this research could significantly impact therapeutic practices and improve the lives of those living with disorders like schizophrenia and ASD.